Table 1. The prognostic value of immune checkpoint genes in breast cancer.

Gene	Affymetrix IDs	OS			RFS
		HR	95% CI	P-value	HR	95% CI	P-value
ADORA2A	205013_s_at	0.91	0.74–1.13	0.4	0.83	0.75–0.93	0.00093
LAG-3	206486_at	0.94	0.76–1.17	0.59	0.88	0.79–0.99	0.026
TIM-3	235458_at	1.07	0.78–1.46	0.67	1.09	0.93–1.27	0.3
PD1	207634_at	0.84	0.68–1.04	0.11	0.74	0.67–0.83	8.5E-08
CTLA-4	236341_at	0.55	0.4–0.76	0.00023	0.67	0.57–0.78	4.2E-07
IDO1	210029_at	0.84	0.68–1.04	0.11	0.89	0.8–0.99	0.034
B7-H3	224859_at	1.38	1–1.9	0.048	1.18	1.01–1.38	0.035
TIGIT	240070_at	0.67	0.49–0.92	0.012	0.77	0.66–0.9	0.0011
CD80	1554519_at	0.84	0.61–1.14	0.26	0.9	0.77–1.05	0.19
CD86	205685_at	0.97	0.78–1.2	0.78	0.93	0.83–1.04	0.19
CD28	206545_at	0.82	0.66–1.02	0.08	0.71	0.64–0.79	1.1E-09
CD160	207840_at	0.88	0.71–1.09	0.26	0.75	0.67–0.84	2.80E-07
LIGHT	207907_at	0.94	0.76–1.17	0.6	0.84	0.76–0.94	0.0024
CD40	215346_at	0.81	0.65–1	0.05	0.81	0.73–0.9	0.00017
CD40LG	207892_at	0.83	0.67–1.03	0.096	0.8	0.71–0.89	3.90E-05
CD200	209583_s_at	0.85	0.69–1.06	0.15	0.82	0.73–0.91	0.00034